The increased expression of monocarboxylate transporter 1 (MCT1), another lactate transporter very well studied in cancer, is part of a pro-metastatic cell phenotype, being associated to the activation of NF-κβ pathway, which also regulates ECM degradation and EMT induction (71). Here, SLC16A1 is linked to cancer.